SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

Kanal Singh, Jason W. Van Winkle, Viviane Callier et al.|The Journal of Infectious Diseases|2024

Cited by 13